{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:35:05Z","timestamp":1779348905273,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[1993,4]]},"DOI":"10.1378\/chest.103.4.1068","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T13:28:23Z","timestamp":1194442103000},"page":"1068-1073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effects of Flecainide and Propafenone on Systolic Performance in Subjects with Normal Cardiac Function"],"prefix":"10.1016","volume":"103","author":[{"given":"Vincenzo","family":"Santinelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarosaria","family":"Arnese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igino","family":"Oppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crescenzo","family":"Matarazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Maione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.103.4.1068_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1056\/NEJM198108273050901","article-title":"Oral flecainide acetate for the treatment of ventricular arrhythmias","volume":"305","author":"Anderson","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.103.4.1068_bib2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0002-9149(81)90331-3","article-title":"Suppression of resistant ventricular arrhythmias by twice daily dosing of flecainide","volume":"48","author":"Duff","year":"1981","journal-title":"Am J Cardiol"},{"issue":"suppl 4","key":"10.1378\/chest.103.4.1068_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003495-198500294-00005","article-title":"Long term use of flecainide in patients wih supraventricular tachycardia","volume":"29","author":"Neuss","year":"1985","journal-title":"Drugs"},{"key":"10.1378\/chest.103.4.1068_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0002-9149(86)90245-6","article-title":"Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate","volume":"58","author":"Kimm","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib5","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-9149(87)91178-7","article-title":"Flecainide acetate for conversion of supraventricular tachycardia to sinus rhythm","volume":"59","author":"Crozier","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/01.CIR.83.1.119","article-title":"Flecainide acetate prevents recurrence of symptomatic paroxysmal supraventricular tachycardia","volume":"83","author":"Henthorn","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.103.4.1068_bib7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/0002-8703(88)90741-7","article-title":"Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study","volume":"116","author":"Singh","year":"1988","journal-title":"Am Heart J"},{"key":"10.1378\/chest.103.4.1068_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.eurheartj.a061826","article-title":"Efficacy of oral propafenone on chronic ventricular arrhythmias: a placebo controlled cross-over exercise study","volume":"6","author":"Hartel","year":"1985","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.103.4.1068_bib9","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0735-1097(87)80479-5","article-title":"Double blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia","volume":"9","author":"Hammill","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib10","doi-asserted-by":"crossref","first-page":"60D","DOI":"10.1016\/S0002-9149(84)80288-X","article-title":"European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias","volume":"54","author":"Coumel","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/0002-9149(88)90373-6","article-title":"Propafenone for prevention of recurrent atrial fibrillation","volume":"61","author":"Kerr","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib12","doi-asserted-by":"crossref","first-page":"89B","DOI":"10.1016\/0002-9149(84)90509-5","article-title":"Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram","volume":"53","author":"Monganroth","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib13","doi-asserted-by":"crossref","unstructured":"The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406\u201312","DOI":"10.1056\/NEJM198908103210629"},{"key":"10.1378\/chest.103.4.1068_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2125.1983.tb02143.x","article-title":"The haemodynamic effect of intravenous flecainide acetate in patients with coronary artery disease","volume":"16","author":"Serruys","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1378\/chest.103.4.1068_bib15","doi-asserted-by":"crossref","first-page":"95B","DOI":"10.1016\/0002-9149(84)90510-1","article-title":"Effects of flecainide on ventricular function: clinical and experimental correlations","volume":"53","author":"Josephson","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib16","first-page":"357","article-title":"La flecainide oral dans le traitement des arythimies rebelles: suivi a long term de 98 patients","volume":"80","author":"Haissaguerre","year":"1987","journal-title":"Arch Mal Coeur"},{"key":"10.1378\/chest.103.4.1068_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.CIR.83.1.345","article-title":"Flecainide acetate for long term prevention of paroxysmal supraventricular tachyarrhythmias","volume":"83","author":"Benditt","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.103.4.1068_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/eurheartj\/8.suppl_A.27","article-title":"Propafenone: a review of its profile","author":"Shlepper","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.103.4.1068_bib19","first-page":"518","article-title":"Propafenone","volume":"22","author":"Funck-Brentano","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.103.4.1068_bib20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"The Committee on M-mode Standardization of the American Society of Echocardiography. Recommendations regarding quantitation of M-mode echocardiography: results of a series of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"10.1378\/chest.103.4.1068_bib21","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0002-9149(83)80073-3","article-title":"Hemodynamic Effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease","volume":"51","author":"Legrand","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib22","first-page":"289","article-title":"Hemodynamic effects of flecainide in acute myocardial infarction (MI) [abstract]","volume":"5","author":"Jackson","year":"1984","journal-title":"Eur Heart J"},{"issue":"B","key":"10.1378\/chest.103.4.1068_bib23","first-page":"113","article-title":"Haemodynamic effects of infused flecainide acetate in myocardial infarction","volume":"5","author":"Silke","year":"1984","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.103.4.1068_bib24","first-page":"364A","article-title":"Pharmacological activity of 5-hydroxypropafenone, a major metabolite of propafenone in man [abstract]","volume":"36","author":"Haefeli","year":"1988","journal-title":"Clin Res"},{"key":"10.1378\/chest.103.4.1068_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/0002-8703(84)90080-2","article-title":"Electrophysiologic and hemodynamic effects of propafenone: a new antiarrhythmic agent on the anesthetized, closed chest dog: comparative study with lidocaine","volume":"107","author":"Katagueuztan","year":"1984","journal-title":"Am Heart J"},{"key":"10.1378\/chest.103.4.1068_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0002-9149(84)90687-8","article-title":"A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes","volume":"53","author":"Salerno","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib27","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0002-8703(88)90522-4","article-title":"Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: a two-year experience","volume":"115","author":"Dinh","year":"1988","journal-title":"Am Heart J"},{"key":"10.1378\/chest.103.4.1068_bib28","doi-asserted-by":"crossref","first-page":"20D","DOI":"10.1016\/S0002-9149(84)80280-5","article-title":"Effect of propafenone on left ventricular ejection fraction","volume":"54","author":"Baker","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.103.4.1068_bib29","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-8703(85)90459-4","article-title":"Propafenone therapy for ventricular tachycardia in the setting of congestive heart failure","volume":"110","author":"Brodsky","year":"1985","journal-title":"Am Heart J"},{"key":"10.1378\/chest.103.4.1068_bib30","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0002-8703(89)90252-4","article-title":"The use of antiarrhythmic agents in heart failure: implications of CAST","volume":"118","author":"Gottlieb","year":"1989","journal-title":"Am Heart J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215417945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215417945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:14:51Z","timestamp":1757920491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215417945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["S0012369215417945"],"URL":"https:\/\/doi.org\/10.1378\/chest.103.4.1068","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[1993,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Flecainide and Propafenone on Systolic Performance in Subjects with Normal Cardiac Function","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.103.4.1068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1993 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}